复星医药自主研发的1类新药芦沃美替尼片完成全国头批发货,为罕见病患者带来新希望。该药快速获批上市,彰显复星医药高效执行力和对患者需求的高度重视。此外,复星医药在创新药布局中不断推进,包括罕见病药物研发和国际化进程。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.